ATLASAbbVie (ABBV) earnings date: expected January 28 – February 3
AbbVie (ABBV) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 28 – February 3. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ABBV
| Last price | $294.89 (+1.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
| Dividend | $6.92 a year (2.35% yield) |
These figures come from the same calibrated model and valuation as the AbbVie stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 28 – February 3 (estimate). One email the day before, with ATLAS’s read on AbbVie. You can switch it off at any time.
Alert me before ABBV reportsFree to start. Creating an account takes under a minute.
ABBV earnings at a glance
| Next report | Not announced · expected around January 28 – February 3 (ATLAS estimate) |
|---|---|
| Last report | Oct 30, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +3.3% |
| Average move around a report | ±3.4% (last 4) |
| Sector | Healthcare · Drug Manufacturers - General |
The expected window is an ATLAS estimate: it takes the typical gap between AbbVie’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
AbbVie earnings history: last 5 reports
AbbVie last reported on Oct 30, 2026: EPS of $3.82 against an estimate of $3.74 (+2.1% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.74 | $3.82 | +2.1% | Beat | – |
| Jul 31, 2026 | $3.61 | $3.65 | +1.1% | In line | -4.8% |
| Jun 18, 2026 | $1.59 | $1.58 | -0.6% | In line | +4.0% |
| Apr 28, 2026 | $4.82 | $4.97 | +3.1% | Beat | +3.3% |
| Apr 20, 2026 | $0.83 | $0.92 | +10.8% | Beat | -1.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ABBV
See the fair value, the probability range and the earnings history of AbbVie on its ATLAS page.
AbbVie (ABBV) stock analysisPlans from €3.99 a month.
AbbVie earnings: frequently asked questions
When is AbbVie (ABBV) next earnings date?
AbbVie has not announced its next report. Its last 3 reports came Oct 30, 2026, Jul 31, 2026, Apr 28, 2026, so ATLAS estimates the next one around January 28 – February 3. This is an estimate based on that pattern, not a confirmed date.
How often does ABBV beat earnings estimates?
Of its last 5 reports with a recorded result, AbbVie beat the EPS estimate 3 times; the average surprise was +3.3%. Past results do not predict the next one.
How much does ABBV move around earnings?
Over its last 4 reports the stock moved an average of 3.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did AbbVie beat earnings estimates last quarter?
AbbVie last reported on Oct 30, 2026: EPS of $3.82 against an estimate of $3.74 (+2.1% surprise), a beat.
How much does ABBV usually move in a day?
On a normal trading day the ATLAS model puts ABBV’s one-day range at about ±1.2%, with a 51% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer